ISELIN, New Jersey and MILTON KEYNES, England, June 29, 2016 /PRNewswire/ --
Indegene (www.indegene.com), a leading global provider of clinical, commercial, and marketing solutions to life science, pharmaceutical, and healthcare organizations, and IndigoMedical (http://www.indigomedical.co.uk/), a renowned provider of medical communications and review/approval services, announced an alliance to provide promotional/medical review and approval solutions to biopharmaceutical companies across the globe. The partnership is set to unite the specialties and values of both the organizations, providing full-spectrum solutions in a simplified, scalable, flexible, cost-effective model that offers shorter time-to-market, minimal compliance risk, and maximized operational efficiency.
The Indegene-IndigoMedical alliance offers a modular set of solutions, including medical review (technical and nominated signatory), editorial services (proofreading and fact check), and operations support (coordination, reference tagging/uploading, and asset management).
Both companies have deep medical expertise across therapy areas and a complete understanding of the review process across pharmaceutical companies. Their teams are conversant with the requirements of regional (EFPIA) and national regulations in a range of countries such as the US, UK, and Canada. The teams combined have 35+ work years' experience in medical review and nominated signatory engagements and 100+ work years' experience in editorial services, with extensive proficiency in Veeva Vault, Aprimo, and Zinc platforms. The new alliance now covers engagements with 7 of the top 20 Pharma companies, providing review and approval outcomes that meet 99%+ accuracy and 100% compliance.
The Indegene-IndigoMedical alliance offers the flexibility of opting between or for a combination of FTE and time-material engagements to manage fluctuating workload. They also offer both onsite (US or UK) and offshore (India) staff deployment based on the client requirement to ensure smooth, seamless, well-coordinated round-the-clock functioning, with 100% accuracy and minimal compliance risk.
Mr. Manish Gupta, CEO, Indegene, said, "We are excited to set up a partnership with IndigoMedical, a uniquely experienced medical communications organization. Through this partnership, our highly experienced teams with deep expertise will provide global delivery of the full spectrum of promotional and medical review to our biopharmaceutical clients across the globe."
Tina Patel, Managing Director, IndigoMedical, stated, "We are delighted to be collaborating with Indegene, which shares our vision for quality service delivery of solutions that meet our clients' needs. Through their global infrastructure and our expertise in promotional and medical review, we can innovate and shape how companies manage this critical but demanding requirement of their business."
Indegene is a leading provider of clinical, commercial, and marketing solutions to global pharmaceutical and healthcare organizations. By seamlessly integrating analytics, technology, operations, and medical expertise (ATOM), Indegene partners with clients to increase both productivity and revenues by delivering better patient outcomes, optimizing cost, enhancing R&D agility, and improving sales and marketing effectiveness. Indegene applies deep scientific knowledge, flexible delivery models, proprietary technology, and a client-centric approach to drive transformational initiatives in drug safety, regulatory and medical affairs, e-learning and development, data analytics, and multichannel customer engagement.
With offices in the United States, United Kingdom, Canada, China, India, and Australia, Indegene partners globally with clients; leverages a global talent pool of clinicians, technologists, creative specialists, domain experts, and business process specialists; deploys global infrastructure assets; and harnesses global healthcare knowledge to solve client challenges.
IndigoMedical is a specialist medical communications and compliance organization based in the UK and US. With a dedicated team of experienced nominated signatories and technical reviewers, we partner with biopharmaceutical companies to provide industry leading review and approval services as well as innovative medical communications. Our approach of hiring from within the industry ensures our company understands our clients' challenges and constraints. All our engagements are led by senior directors, ensuring rapid decision making and insightful advice based on years of industry experience, facilitating efficient delivery. As a company, we value partnership, high-quality delivery and delighted clients. Challenging problems and innovative solutions, these are what drive and excite us.